Geode Capital Management, LLC Brooklyn Immuno Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.48 - $2.03 $103,830 - $439,117	-216,314 Reduced 47.01%	243,805 $126,000
Q1 2022 May 13, 2022	SELL	$1.76 - $4.84 $15,403 - $42,359	-8,752 Reduced 1.87%	460,119 $943,000
Q4 2021 Feb 11, 2022	BUY	$4.17 - $9.79 $159,298 - $373,987	38,201 Added 8.87%	468,871 $1.96 Million
Q3 2021 Nov 12, 2021	BUY	$8.86 - $17.05 $646,018 - $1.24 Million	72,914 Added 20.38%	430,670 $4.01 Million
Q2 2021 Aug 13, 2021	BUY	$3.75 - $78.5 $1.3 Million - $27.3 Million	347,167 Added 3278.56%	357,756 $6.44 Million
Q1 2021 May 12, 2021	BUY	$3.72 - $12.76 $39,391 - $135,115	10,589 New	10,589 $39,000

1.21M

Ticker BTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,825,700
Description
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.